Here's an honest comparison of what you're getting
Both peptides represent the next wave of treatments for people who have not found success with older options
Murphy MG, Plunkett LM, Gertz BJ, et al
At microdose levels, the signal is weighted toward GIP, with less GLP-1 appetite suppression and less glucagon-related heart-rate cost than higher doses
AOD 9604 With Retatrutide: Evidence, Safety, and UK Regulatory Status AOD 9604 with retatrutide is a combination increasingly discussed in weight-loss and body-composition circles, yet neither compound holds a Marketing Authorisation from the MHRA or EMA for use in the UK
Go with proven combinations, begin with small doses, and titrate based on response and labs